Poison Pills, Explained
The corporate defense that made hostile takeovers ten times harder, how the shareholder rights plan works, and why it changed the balance of power in the boardroom.
By the mid-1980s, corporate America was tired of being hunted. The raiders had cheap debt, a junk-bond market, and a simple method: buy enough stock on the open market to seize control before management could react. Boards needed a defense that worked before a raider reached a controlling stake. They got one, and it is still the single most important takeover defense in use today.
It has a formal name, the shareholder rights plan. Everyone calls it the poison pill.
How it works
A poison pill is a right distributed to every existing shareholder. The right lies dormant and harmless, until a hostile buyer crosses a defined ownership threshold, often somewhere around 10 to 20 percent of the company, without the board’s approval.
At that moment, the pill triggers. Every shareholder except the hostile buyer gets to purchase additional shares at a steep discount. The result is brutal arithmetic: the company floods itself with new, cheap stock, and the raider’s carefully accumulated stake is suddenly diluted, its ownership percentage and its dollar value both collapse.
The pill does not poison the company. It poisons the raider’s own position.
Crucially, the board can redeem the pill, switch it off, at any time. So the pill does not actually prevent the company from being sold. It prevents the company from being taken without the directors’ consent.
Why it mattered
That distinction is the whole point. Before the poison pill, a determined raider with enough financing could route around the board entirely, going straight to shareholders with a tender offer or open-market buying. The pill closed that route.
After the pill, virtually every hostile bid had to come through the boardroom. The raider could no longer simply buy the company; the raider had to convince, or pressure, or replace via a proxy fight, the directors who held the off switch. Leverage shifted back toward the board.
The limits
The pill is powerful, but it is not absolute. Courts, Delaware’s especially, have consistently held that a board may use a pill to protect shareholders and buy time to seek a better deal, but not to entrench itself indefinitely against the shareholders’ clear wishes.
A pill is a negotiating tool, not a fortress. It changed hostile takeovers from a raid into a negotiation, which, for the boards of the 1980s, was exactly the point.
Key Takeaways What this deal teaches
- 01 A poison pill makes a hostile buyer's own shares detonate their stake's value.
- 02 It does not block a takeover, it forces the bidder to negotiate with the board.
- 03 The pill shifts leverage from the raider back to the directors.
- 04 Like any defense, courts will not let a board use it to entrench itself forever.
Published February 18, 2025